Results 211 to 220 of about 611,546 (266)

The Use of Statins in Parkinson's and Alzheimer's Disease: A 2021-2025 State-of-the-Art Review of Clinical and Preclinical Evidence. [PDF]

Pharmacol Res Perspect
Chiatto LM, Buccarello L, Carota G, Calabrò RS, Rifici C, Esposito E, Ardizzone A, Caruso G.   +7 more
europepmc   +1 more source

The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study. [PDF]

J Neurol
Hegen H, Föttinger F, Walde J, Berek K, Martinez-Serrat M, Damulina A, Krajnc N, Ponleitner M, Di Pauli F, Enzinger C, Deisenhammer F, Berger T, Khalil M, Bsteh G, Austrian Multiple Sclerosis Database Study group.   +14 more
europepmc   +1 more source

Genetic analysis of polyadenylation patterns reveals distinct classes of yeast genes and local chromatin effects on Pol II elongation. [PDF]

Genetics
Moqtaderi Z, Geisberg JV, Struhl K.
europepmc   +1 more source

Intra-Articular Cyclo(His-Pro) Attenuates Monosodium Iodoacetate-Induced Osteoarthritis by Suppressing COX-2/PGE₂ Signaling and Cartilage Catabolism in Rats. [PDF]

Int J Mol Sci
Huh G, Lee D, Jeon J, Kim D, Jung HY.
europepmc   +1 more source

Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE₄ heterozygotes and non-carriers. [PDF]

J Prev Alzheimers Dis
Hazan J, Liu KY, Howard R.
europepmc   +1 more source

Correction to Favorable and poor prognosis B-cell precursor acute lymphoblastic leukemia subtypes reveal distinct leukemic cell properties when interacting with mesenchymal stem cells, differentially modifying their cell stemness and leukemia chemoresistance. [PDF]

J Cell Commun Signal
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Modifying the Modifier

Science Signaling, 2009
An oxygenase with an important role in vertebrate development hydroxylates a messenger RNA-splicing factor.
openaire   +2 more sources